APA (7th ed.) Citation

P, M., JS, N., & JP, F. (2026). Targeted Potassium Levels, Mineralocorticoid Receptor Antagonism, and Cardiovascular Outcomes in Patients With High Arrhythmic Risk: A Reinterpretation of the POTCAST Trial. Journal of cardiac failure. https://doi.org/10.1016/j.cardfail.2026.03.027

Chicago Style (17th ed.) Citation

P, Marques, Neves JS, and Ferreira JP. "Targeted Potassium Levels, Mineralocorticoid Receptor Antagonism, and Cardiovascular Outcomes in Patients With High Arrhythmic Risk: A Reinterpretation of the POTCAST Trial." Journal of Cardiac Failure 2026. https://doi.org/10.1016/j.cardfail.2026.03.027.

MLA (9th ed.) Citation

P, Marques, et al. "Targeted Potassium Levels, Mineralocorticoid Receptor Antagonism, and Cardiovascular Outcomes in Patients With High Arrhythmic Risk: A Reinterpretation of the POTCAST Trial." Journal of Cardiac Failure, 2026, https://doi.org/10.1016/j.cardfail.2026.03.027.